Wistron Medical expects rising sales in 2021

Aaron Lee, Taipei; Joseph Tsai, DIGITIMES Asia 0

Wistron Medical Technology, an affiliate of the Wistron Group, sees good progress in medical product developments and expects its medical solutions to drive up the company's sales in 2021, according to company president Donald Hwang.

Wistron Medical has partnered with Canada-based B-Temia to develop the Keeogo walking assistance device, which has already obtained certifications and begun selling in Taiwan, the US, the EU, Malaysia and Singapore, Hwang noted.

Keeogo features patented technologies using sensors to detect the angles of users' knee joints to predict their moves, Hwang said.

The device is currently being certified by the China, South Korea and Thailand governments, and will be available in more markets in 2021, Hwang said.

In Taiwan, Wistron Medical is keenly promoting the device to local hospitals and nursing homes, Hwang said.

Wistron Medical is also developing external inspection and smart medical care applications. The company is set to unveil a smart exoskeleton solution and a device for hand rehabilitation by year-end 2020, Hwang noted.

The company's external inspection solutions, including mobile handheld devices and lab equipment, have already been adopted by five clients so far, Hwang said.

Wistron Medical is still in the red due to the high expenses spent on certifications.

Wistron Medical president Donald Hwang.

Wistron Medical president Donald Hwang
Photo: Michael Lee, Digitimes file photo